Kyoto University Amgen Scholars Program 2020 – Cancelled
After careful consideration, and with deep concerns for the health and safety of participants, Kyoto University has regrettably decided to cancel the Kyoto University Amgen Scholars Program 2020 scheduled to take place from June 9 to August 3. In addition, the Amgen Scholars Asia Symposium 2020 scheduled to take place from August 6 to August 8 in Singapore has also been cancelled.
We are sincerely grateful for all your applications to the 2020 program and hope that you would once again be able to apply for the 2021 program if possible.
As you are all undoubtedly aware, we are now facing to an unprecedented threat caused by the global COVID-19 pandemic.
We hope that the Amgen Scholars Program applicants, who are all interested in bioscience, biotechnology and drug discovery, will take the necessary and appropriate actions to guard their own life, their family and the people around them.
Additionally, we should not forget that there are still, and will be more infectious diseases other than COVID-19 in existence that will be a threat to many people in the world.
We hope that all of you will manage to overcome this difficulty we are currently facing, continue your education to become scientists who will counter challenges such as that we are facing with the power of science and technology while cooperating with each other and we hope to see you someday in Japan.
Kyoto University Amgen Scholars Program
- Application period opens
- 3 p.m. on November 1, 2019 (UTC+9 hours)
- Application deadline
- 3 p.m. on February 3, 2020 (UTC+9 hours)
- Notification of results
- Early April 2020
- Arrival (in Japan)
- June 8, 2020
- Program period
- June 9 – August 8, 2020 (*)
- Symposium (in Singapore)
- August 6 – August 8, 2020
- Departure (from Singapore)
- August 9, 2020
*The program period includes the dates of the symposium.
Apply to the program (* Link is available only during the application period)
Application for the 2020 program has been closed.
The Amgen Scholars Program is made possible by generous funding from the Amgen Foundation.